Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Breaks Above 50 Day Moving Average – Here’s Why

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH) passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $9.80 and traded as high as $10.26. Cipher Pharmaceuticals shares last traded at $9.94, with a volume of 18,110 shares traded.

Cipher Pharmaceuticals Stock Up 4.1%

The firm’s 50-day simple moving average is $9.80 and its 200 day simple moving average is $11.33.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused primarily on developing, acquiring, and commercializing medicines for dermatology and other areas with unmet medical needs. The company’s business model emphasizes licensing and advancing differentiated prescription products rather than maintaining a broad, traditional drug-discovery operation. Cipher’s dermatology portfolio has included Epuris, an oral isotretinoin product used to treat severe acne, as well as products for conditions such as actinic keratosis and excessive facial hair.